# Tranexamic Acid Dosing for Total Joint Arthroplasty

> **NCT02584725** · PHASE4 · COMPLETED · sponsor: **Columbia University** · enrollment: 84 (actual)

## Conditions studied

- Arthropathy of Hip
- Arthropathy of Knee

## Interventions

- **DRUG:** Tranexamic Acid

## Key facts

- **NCT ID:** NCT02584725
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2020-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02584725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02584725, "Tranexamic Acid Dosing for Total Joint Arthroplasty". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02584725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*